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Abstract  
For reasons not clearly understood, Acute Lung Injury (ALI), often caused by 
systemic infections or severe trauma, leads to Acute Respiratory Distress Syndrome 
(ARDS), which is characterized by pulmonary edema and leukocyte infiltration, and 
affects 100,000 Americans annually. Phospholipase A2 (PLA2) enzyme, able to cleave 
phospholipids, is the target of signal transduction cascades, and plays a role in several 
bodily functions. PLA2 group 2A specifically hydrolyzes surfactant phospholipids in-
vitro. The objective of this study is to determine whether PLA2 enzymes are produced 
and subsequently secreted by A549 lung epithelial cells in response to cytokine 
stimulation (and, more generally, to infection or ALI). It was found that TNF! + IL-6 
stimulation in particular induces increased production but not necessarily secretion of 
PLA2 in A549 cells. This finding supports the hypothesis that PLA2 enzymes help 
mediate the inflammatory responses initiated in ARDS. 
 
Introduction 
Phospholipase A2 enzymes (PLA2) have the known function of cleaving 
phospholipids at the sn-2 position of glycerol as part of signal transduction cascades. 
Certain studies have shown that PLA2 propagates inflammatory responses triggered by 
cytokines such as TNF! and IL-6. PLA2 is important in many physiological processes, 
including lipoprotein metabolism and atherogenesis (Kovanen et al., 2000) and the 
development of cancer (Belinsky et al., 2007). 
Another physiological condition in which PLA2 is thought to play a role is Acute 
Respiratory Distress Syndrome (ARDS). The exact mechanism by which ARDS sets in is 
unclear but there is mounting evidence that hydrolysis of pulmonary surfactants plays an 
important part in the development of this condition. The first step is believed to be an 
Acute Lung Injury (ALI) caused by systemic infections, severe trauma or exposure to 
hazardous chemicals, such as phosgene (Chen et al., 2009). ALI is thought to induce 
cytokine release and secretion of PLA2, which would then hydrolyze pulmonary 
surfactant. 
Indeed, studies of ARDS in rodent model systems have confirmed that secreted 
PLA2 Group 2A (G2A) hydrolyzes surfactant phospholipids (Touqui et al, 2003). Other 
enzymes are likely involved in this process and one possible candidate is PLA2 Group 10 
(G10), which is produced in lung tissues and is secreted into extracellular spaces 
(Cupillard et al., 1997). Although the role of PLA2 in human ARDS has not been 
unambiguously established, this lab (Bowlton et al., 1997) and others (Kim et al., 1995) 
have previously described elevated levels of PLA2 in bronchoalveolar lavage (BAL) 
fluids of patients suffering from asthma or ARDS. 
In this investigation, we test the hypothesis that human epithelial lung cells produce 
and secrete PLA2 in response to ALI. A549 human epithelial lung cells were stimulated 
with cytokines to mimic the conditions of ALI. Immunohistochemistry was used to 
monitor the presence of G2A and G10 on cell membranes and ELISA experiments 
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measured the concentration of G2A in the extracellular medium. It was found that 
cytokine stimulation increased the amount of membrane-bound G2A and G10 but did not 
cause these enzymes to be secreted into the extracellular matrix. 
 
Materials and Methods 
Immunohistochemistry Cell Cultures: A549 cells were grown under liquid RPMI 
media and were incubated with one of four possible cytokine stimulants: (a) no 
stimulants (NS; negative control), (b) IL-8, (c) TNF!, or (d) a combination of TNF! and 
IL-6. At 6 hours and/or 24 hours post-stimulation, the RPMI media was removed by 
aspiration and cells were washed in PBS and then fixed with Formalin. 
Immunohistochemistry reactions were performed using an ABC immunoperoxidase kit 
(Vectastain – Vector Laboratories, Burlingame, CA).  Fixed cells were briefly blocked 
with normal serum blocking agent and incubated with one of three possible rabbit anti-
human primary antibodies: (i) non-specific IgG (negative control\), (ii) anti-G2A 
antibody (IIA; source: Cayman Chemical, Ann Arbor, MI), or (iii) anti-G10 antibody (X). 
The samples were then incubated with a goat anti-rabbit secondary antibody linked to 
biotin. Staining was carried out by adding streptavidin-linked peroxidase and NOVA 
RED peroxidase substrate (Vector Laboratories). Digital micrographs of the stained 
samples were taken at either 100x or 400x magnification. All micrographs were taken 
with identical, manually-set exposures for each experiment. 
PLA2 Group 2A ELISA: Extracellular concentrations of the G2A protein were 
quantified with an EIA assay kit (Cayman Chemical) according to the manufacturer’s 
instructions. A549 cells were grown to confluence under liquid RPMI in petri dishes, as 
described above, in the presence and absence of IL-8. After being grown overnight, 
RPMI media was removed by pipette and transferred to micro-centrifuge tubes. The 
supernatants were then assayed for levels of G2A. Hep G2 cells (which have been shown 
to produce and secrete G2A) (Crowl et al., 1991) were used as a positive control for this 
experiment. Absorbance measurements were taken at 60 and 120 minutes after media 
was removed. 
 
Results and Discussion 
In order to determine whether cytokine stimulation induces PLA2 production, we 
first had to assess the levels of production of this enzyme in the absence of cytokine 
stimulation. A549 cells were incubated for 6 hours and were subsequently assayed for the 
G2A PLA2 enzyme via immunohistochemistry using the IIA antibody. Images 
corresponding to these reactions are shown in figure 1. 
The results in Figure 1 show some differences in staining pattern between the 
reactions run with the nonspecific IgG and the IIA antibody. The results from the 
reactions with IIA (panels b and d) look similar to those from the reactions performed 
with nonspecific IgG (a and c), suggesting that the staining observed is due to a cross-
reactivity phenomenon rather than a genuine antibody-antigen reaction. Thus, this data 
suggests that there is very little G2A production in the absence of cytokine stimulus. This 
data is consistent with the hypothesis that G2A production is induced by cytokine 
stimulation.  As an aside, the experiments in Figure 1 also show that nonspecific IgG 
binding can be used to approximate the number of cells present in each slide. Knowing 
the approximate number of cells present on each slide allows one to gauge whether 
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differences in staining are due to differences in cell number versus levels of protein 
production. 
The next step of the investigation was to compare the levels of G2A in both the 
presence and absence of cytokine stimulation. After 6 hours of incubation, the cells were 
assayed via immunohistochemistry procedures using either IgG or IIA. Figure 2 and 3 
show the images obtained from these experiments. 
The images from the IgG control reactions (2a-d and 3a-c) are qualitatively equal: 
staining is roughly constant and does not greatly depend on cytokine stimulus. Although 
figure 3d shows somewhat darker staining compared with its counterparts (3a-c), this is 
most likely an erroneous result. The corresponding low-magnification image (2d) shows 
lighter staining than its control (2a).  
In both figure 2 and figure 3, the level of staining for reactions lacking cytokines (2a, 
2e, 3a and 3e) is the same for the IgG and IIA reactions. These results agree with the data 
in figure 1. Once cytokines are added to the reaction mixture, the IIA reactions show 
noticeably darker staining than their corresponding controls (2f-h and 3f-h). 
Thus, A549 cells substantially increase membrane levels of G2A in response to 
cytokine stimulus. Moreover, one can qualitatively determine which cytokines are most 
effective at inducing G2A production. Panels 2e-h show that IL-8 stimulation yields 
approximately the same increase in staining as TNF! stimulation. The combination of 
TNF! and IL-6, however, results in much darker staining, indicating that this stimulation 
mixture is effective at inducing G2A production. The same pattern is seen in panels 3e-h, 
although the contrast in staining is slightly less pronounced. 
The production of G2A by A549 cells was subsequently tested via 
immunohistochemistry under a variety of conditions in order to ascertain how prolonged 
exposure to cytokines affects the expression of this enzyme. The effect of cytokine 
stimulation on the production of G10 was also tested by immunohistochemistry methods. 
The data in figure shows low-magnification images from the experiments performed. 
The images from panels 2d and 2h are shown again in figures 4a and 4e; recall that these 
data were obtained after 6 hours of stimulation. Next to them are images obtained from 
assaying A549 cells incubated with TNF! alone for 24 hours (4b and 4f). These figures 
show that longer incubation times with TNF! alone results in much the same increase in 
G2A levels as synergistic stimulation with TNF! and IL-6. 
The effect of TNF! on G10 production was probed under exactly the same 
conditions that were used to generate the data in figures 4b and 4f. A positive reaction 
was observed with X (4g) relative to the corresponding control trial (4c), indicating that 
TNF! stimulation also elicits G10 production. Likewise, the darker staining in panel 4h 
relative to the control reaction in panel 4d suggests that IL-8 increases G10 production as 
well. The latter reactions were assayed after 6 hours of incubation, whereas the 
experiments depicted in panels 4c and 4g were incubated for 24 hours. One should also 
note that the darker staining in the TNF! / X reactions is due to an apparently greater cell 
density than those found in the IL-8 / X reactions (figure 4c versus 4d). As such, the 
levels of G10 expression in both experiments should be considered approximately equal. 
In order to gauge the relative effects of cytokine stimulation on G2A and G10 
production, A549 cells were incubated with cytokines for 6 hours and then assayed for 
either G2A or G10 via immunohistochemistry (figure 5). The images in panels 5a, 5b, 5e 
and 5f reproduce the results from figures 2 and 3, which establish that the combination of 
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TNF! and IL-6 is the most effective stimulant for inducing G2A production. Panels 5c, 
5d, 5g and 5h, on the other hand, show that G10 expression is greater when A549 cells 
are stimulated with IL-8 rather than TNF!. The latter observation is consistent with the 
data in panels 4g and 4h, which show that 24 hours of TNF! stimulation is needed to 
attain levels of G10 production comparable to those induced by 6 hours of IL-8 
stimulation. Taken together, the data in figures 4 and 5 suggest that TNF! preferentially 
induces G2A production while G10 production responds better to IL-8 stimulation. 
The immunohistochemistry experiments performed thus far, shown in figures 1 
through 5, have shown that A549 cells increase production of both G2A and G10 in 
response to cytokine stimulation. These observations therefore provide evidence for 
PLA2 enzymes in mediating epithelial cell reactions to inflammation, confirming the first 
part of this investigation’s hypothesis. Immunohistochemistry techniques cannot, 
however, address the second part of this investigation’s hypothesis: namely whether G2A 
is secreted into the extracellular medium upon cytokine stimulus. In order to address this 
question, an ELISA experiment was used. 
A549 cells were incubated in the presence or absence of IL-8 for either 6 or 24 
hours. HepG2 cells, which are known to produce and secrete G2A (Crowl et al., 1991), 
were grown in parallel with the A549 cells as a positive control. After the incubation time 
had elapsed, the RPMI media was extracted by pipette and analyzed by ELISA, as per the 
techniques described. The extracellular G2A concentration (pg/mL) in the RPMI media 
from both A549 and HepG2 cells was then measured at 60 and 120 minutes after media 
extraction and the average of these two values was reported in figure 6. 
The ELISA results show that HepG2 cells exhibited robust production and secretion 
of G2A into the extracellular medium. This secretion was not appreciably influenced by 
the presence of cytokines. The data from the HepG2 cell experiments is a useful positive 
control. A549 cells on the other hand, did not secrete G2A into the extracellular medium 
to any appreciable extent in the absence of cytokines. Furthermore, cytokine stimulants 
did not increase levels of G2A. This indicates that, though A549 cells produce G2A, this 
enzyme is retained and is not secreted. 
Thus, the second portion of the experimental hypothesis is incorrect. Thus, we have 
shown that cytokine stimulus does indeed increase levels of G2A and G10 at the plasma 
membrane. We could not, however, find any evidence that G2A is secreted as we had 
initially believed. These findings are potentially relevant for treating the onset and 
progression of ARDS. If the cytokines we studied increase G2A and G10 levels in vivo as 
our data suggest, then inhibiting G2A and G10 activity could form the basis for a new 
therapy for ARDS.  
Alternatively, one could also inhibit the actions of the cytokines which have been 
shown to increase PLA2 levels and our experiments provide a clue as to which cytokines 
would be the best targets for this approach. The data in figure 1 indicate that G2A could 
be produced at a low basal level in the absence of cytokine stimulation. Subsequent 
studies in figures 2 and 3 showed that stimulation with TNF! or IL-8 alone increased 
G2A levels by the same amount. Combined stimulus with TNF! and IL-6 result together 
resulted in a more potent increase in G2A levels. The observed synergy between TNF! 
and IL-6 is consistent with earlier work monitoring G2A secretion by HepG2 cells 
(Crowl et al., 1991). Interestingly, the authors of the latter work showed that IL-6 caused 
the most significant increase in G2A levels. 
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All the same, TNF! is clearly a powerful regulator of G2A levels as evidenced by 
the data in figure 4, which shows that 24 hours of incubation with TNF! alone results in 
the same level of G2A as 6 hours of incubation with TNF! and IL-6. Moreover the data 
in figures 4 and 5 show that levels of G2A are more responsive to TNF! stimulus than 
are G10 levels. Conversely, the same figures show that IL-8 is a stronger activator of G10 
production than is TNF!. The preference is not, however, absolute as the data clearly 
show that both cytokines are capable of increasing G2A and G10 levels. These 
observations could have important therapeutic consequences. If either G2A or G10 is 
implicated in damaging pulmonary surfactant in vivo, then one could preferentially 
attenuate their effects by inhibiting signaling of TNF! or IL-8, respectively. 
The ELISA experiments, however, suggest that A549 cells do not secrete G2A in 
response to cytokine stimulus. Figure 6 shows no change in extracellular G2A levels if 
cytokines are added to the growth medium of A549 cells. Thus, lung epithelial cells 
probably do not secrete the PLA2 in response to cytokine stimulus. In summary, this 
investigation has shown that cytokine stimulus increase production, but not secretion, of 
PLA2 enzymes by lung cells but further study is needed to determine the role of these 
enzymes in mediating disease in vivo. 
 
Conclusion 
As is often the case in science, every answer that was obtained in this investigation 
gave rise to new questions. The data in this investigation clearly show that cytokine 
stimulus in vivo results in increased levels of PLA2 on the cell membrane, in particular 
G2A and G10. The mechanism by which this occurs is still unclear. The observed 
increase could be due to increased synthesis of PLA2 followed by insertion into the 
membrane, or by fusion of PLA2-containing vesicles with the membrane. Furthermore, 
our data showed that TNF! preferentially increases G2A levels while IL-8 preferentially 
increases G10. This selectivity is not absolute, however, as both cytokines increase G2A 
and G10 levels. Again, the molecular mechanism for this specificity is not clear and one 
is left to wonder how these observations relate to the progression of disease in vivo. 
Finally, the ELISA results show that A549 human lung epithelial cells do not secrete 
PLA2 in response to cytokine stimulus and so how this enzyme makes its way into BAL 
fluids remains a mystery. 
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